Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.

Autor:	Chang, Joe Y1 (AUTHOR) jychang@mdanderson.org, Lin, Steven H1 (AUTHOR), Dong, Wenli2 (AUTHOR), Liao, Zhongxing1 (AUTHOR), Gandhi, Saumil J1 (AUTHOR), Gay, Carl M3 (AUTHOR), Zhang, Jianjun3 (AUTHOR), Chun, Stephen G1 (AUTHOR), Elamin, Yasir Y3 (AUTHOR), Fossella, Frank V3 (AUTHOR), Blumenschein, George3 (AUTHOR), Cascone, Tina3 (AUTHOR), Le, Xiuning3 (AUTHOR), Pozadzides, Jenny V3 (AUTHOR), Tsao, Anne3 (AUTHOR), Verma, Vivek1 (AUTHOR), Welsh, James W1 (AUTHOR), Chen, Aileen B1 (AUTHOR), Altan, Mehmet3 (AUTHOR), Mehran, Reza J4 (AUTHOR)
Zdroj:	Lancet. Sep2023, Vol. 402 Issue 10405, p871-881. 11p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu